Black and Hispanic living kidney donors are at increased relative risk for hypertension, diabetes requiring drug therapy, and CKD compared with their white counterparts, according to researchers.

It is associated with better improvements in insulin sensitivity and beta-cell function, study shows.

Patients with both heart failure and type 2 diabetes who are treated with a metformin-based strategy have a lower mortality risk than matched individuals not treated with anti-diabetic drugs, new findings suggest.

More than one third of patients eligible to receive the drugs actually do not get a prescription for them.

A new analysis found that this measure is inferior to the oral glucose tolerance test for screening.

Abbott has received FDA clearance to market FreeStyle Lite glucose test strips. The test strips minimize interference during blood glucose testing and are designed to offer a better experience, Abbott says.

Doctors may be able to head off ESRD and CVD by treating pre-diabetes and pre-hypertension sooner.

MUNICH, GERMANY—Atorvastatin may benefit hemodialysis (HD) patients with type 2 diabetes and high LDL cholesterol levels, a researcher reported at the the European Renal Association-European Dialysis and Transplant Association 2010 Congress.

SAN FRANCISCO—Men with diabetes experience significantly smaller increases in PSA level as they age compared with non-diabetics, according to findings reported here at the American Urological Association Annual Meeting.

SAN FRANCISCO—Among obese white men, those with diabetes mellitus (DM) are more likely than non-diabetics to have high-grade prostate cancer discovered on prostate biopsy, according to researchers.